Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Br J Cancer ; 118(10): 1399-1405, 2018 05.
Article in English | MEDLINE | ID: mdl-29593338

ABSTRACT

BACKGROUND: Consultation with radiation oncologists, in addition to urologists, is advocated for patients diagnosed with prostate cancer. Treatment patterns for patients receiving consultation from radiation oncologists in addition to urologists have not previously been described. METHODS: We conducted a matched cohort study of men with newly diagnosed non-metastatic prostate cancer in Ontario, Canada. Patients who underwent consultation with a radiation oncologist prior to treatment were matched 1:1 with patients managed by a urologist alone based on tumour and patient characteristics. We examined rates of active treatment (surgery or radiotherapy) within one year following diagnosis. RESULTS: Among 5708 matched pairs (11,416 patients), those who received radiation oncology consultation were more likely to undergo active treatments whether they had intermediate or high-risk disease (88.6% vs. 65.9%, p < 0.0001; adjusted odds ratio 4.0, 95% CI: 3.6-4.4) or low-risk disease (56.1% vs. 13.3%, p < 0.0001; adjusted odds ratio 8.4, 95% CI: 6.7-10.6). This effect persisted after considering age, comorbidity, tumour volume and year of diagnosis. CONCLUSIONS: Patients newly diagnosed with prostate cancer who receive radiation oncology consultation are associated with a higher rate of active treatment, compared to patients managed by urologists only. Selection and referral biases, and unmeasured confounding such as patient preference must be considered as important factors attributing this association.


Subject(s)
Patient Selection , Prostatic Neoplasms/radiotherapy , Prostatic Neoplasms/surgery , Aged , Humans , Male , Middle Aged , Ontario , Patient Preference , Practice Patterns, Physicians' , Prostatectomy , Prostatic Neoplasms/epidemiology , Referral and Consultation , Risk , SEER Program , Treatment Outcome
2.
Urol Clin North Am ; 30(4): 819-30, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14680317

ABSTRACT

This review serves as an outline of the clinical features and management options for the majority of recurrence situations in NSGCTs. The combination of reliable serum tumor markers, improved imaging techniques, effective cisplatin chemotherapy regimens, and application of meticulous surgical techniques has resulted in dramatic improvements in cure rates in NSGCT. These factors have caused the incidence of recurrent NSGCT to decline substantially in the past 20 years. This rarity of recurrence in combination with the low incidence of NSGCT prevents the practicing clinician from accumulating experience in this challenging patient population. Therefore, to ensure improvement in salvage rates, patients are best managed in centers with extensive experience in NSGCT.


Subject(s)
Germinoma/therapy , Testicular Neoplasms/therapy , Chemotherapy, Adjuvant , Follow-Up Studies , Humans , Lymph Node Excision , Male , Orchiectomy , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL